<HashMap><database>biostudies-literature</database><scores/><additional><submitter>Karpstein T</submitter><funding>Swiss National Science Foundation</funding><pagination>1335</pagination><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/S-EPMC8537204</full_dataset_link><repository>biostudies-literature</repository><omics_type>Unknown</omics_type><volume>10(10)</volume><pubmed_abstract>Drug-based treatment of alveolar echinococcosis (AE) with benzimidazoles is in most cases non-curative, thus has to be taken lifelong. Here, we report on a 56-year-old male AE patient who received standard benzimidazole treatment and biliary plastic stents, and additionally self-medicated himself with the Peruvian plant extract Maca (Lepidium meyenii). After 42 months, viable parasite tissue had disappeared. Based on this striking observation, the anti-echinococcal activity of Maca was investigated in vitro and in mice experimentally infected with Echinococcus multilocularis metacestodes. Albendazole (ABZ)-treated mice and mice treated with an ABZ+Maca combination exhibited a significantly reduced parasite burden compared to untreated or Maca-treated mice. As shown by a newly established U</pubmed_abstract><journal>Pathogens (Basel, Switzerland)</journal><pubmed_title>Maca against Echinococcosis?-A Reverse Approach from Patient to In Vitro Testing.</pubmed_title><pmcid>PMC8537204</pmcid><funding_grant_id>192072</funding_grant_id><pubmed_authors>Bresson-Hadni S</pubmed_authors><pubmed_authors>Largiader CR</pubmed_authors><pubmed_authors>Rufener R</pubmed_authors><pubmed_authors>Aebi Y</pubmed_authors><pubmed_authors>Hemphill A</pubmed_authors><pubmed_authors>Lundstrom-Stadelmann B</pubmed_authors><pubmed_authors>Chaudhry S</pubmed_authors><pubmed_authors>Schindler I</pubmed_authors><pubmed_authors>Kaethner M</pubmed_authors><pubmed_authors>Boubaker G</pubmed_authors><pubmed_authors>Karpstein T</pubmed_authors><pubmed_authors>Hayoz M</pubmed_authors><pubmed_authors>Cunha AS</pubmed_authors></additional><is_claimable>false</is_claimable><name>Maca against Echinococcosis?-A Reverse Approach from Patient to In Vitro Testing.</name><description>Drug-based treatment of alveolar echinococcosis (AE) with benzimidazoles is in most cases non-curative, thus has to be taken lifelong. Here, we report on a 56-year-old male AE patient who received standard benzimidazole treatment and biliary plastic stents, and additionally self-medicated himself with the Peruvian plant extract Maca (Lepidium meyenii). After 42 months, viable parasite tissue had disappeared. Based on this striking observation, the anti-echinococcal activity of Maca was investigated in vitro and in mice experimentally infected with Echinococcus multilocularis metacestodes. Albendazole (ABZ)-treated mice and mice treated with an ABZ+Maca combination exhibited a significantly reduced parasite burden compared to untreated or Maca-treated mice. As shown by a newly established U</description><dates><release>2021-01-01T00:00:00Z</release><publication>2021 Oct</publication><modification>2025-04-21T14:49:04.558Z</modification><creation>2025-04-21T14:49:04.558Z</creation></dates><accession>S-EPMC8537204</accession><cross_references><pubmed>34684284</pubmed><doi>10.3390/pathogens10101335</doi></cross_references></HashMap>